Hydroxychloroquine and "off-label" Utilization in the Treatment of Oral Conditions
Overview
Authors
Affiliations
Shah S, Pahade A, Chawla R J Anaesthesiol Clin Pharmacol. 2021; 36(4):471-476.
PMID: 33840926 PMC: 8022063. DOI: 10.4103/joacp.JOACP_379_20.
Chloroquine or hydroxychloroquine for prevention and treatment of COVID-19.
Singh B, Ryan H, Kredo T, Chaplin M, Fletcher T Cochrane Database Syst Rev. 2021; 2:CD013587.
PMID: 33624299 PMC: 8094389. DOI: 10.1002/14651858.CD013587.pub2.
SARS-CoV-2 Infection and Oral Health: Therapeutic Opportunities and Challenges.
Coke C, Davison B, Fields N, Fletcher J, Rollings J, Roberson L J Clin Med. 2021; 10(1).
PMID: 33466289 PMC: 7795434. DOI: 10.3390/jcm10010156.